Document is current
Any future updates will be listed below
-
Authors
Rosario, Barbara H. https://orcid.org/0000-0001-5491-3524
Shafi, Humaira
Yii, Anthony C. A.
Tee, Louis Y.
Ang, Arron S. H.
Png, Gek Kheng
Ang, Wendy S. T.
Lee, Yan Qing
Tan, Pei Ting
Sahu, Aniruddha
Zhou, Lin Fang
Zheng, Yi Ling
Slamat, Roslinda Binte
Taha, Aza A. M.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04347395 at ClinicalTrials.govDocuments that mention this clinical trial
Evaluation of multi-component interventions for prevention of nosocomial pneumonia in older adults: a randomized, controlled trial
https://doi.org/10.1007/s41999-021-00506-3
-
Funding
Funding for this research was provided by:
Changi General Hospital Research Grant (Grant number CHF2016.04-P)
- License Information
-
More Information
Article History
Received: 2 November 2020
Accepted: 28 April 2021
First Online: 3 June 2021
Declarations
:
: The main author attended a Pneumococcal Vaccine Expert Input forum in 2019 (an honorarium was received and donated to the Geriatric Department) and received sponsorship from Pfizer to attend an Asia Pneumococcal and Meningococcal Disease Conference in Hong Kong in 2016. The remaining authors declare no conflict of interest, and this paper has not been published or presented elsewhere.
: The trial was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by the SingHealth Centralized Institutional Review Board.
: Written informed consent was obtained by a study team member and if the patient lacked capacity to make decisions then consent was obtained from a legally appointed representative (LAR).
: We certify that this work is novel. It contributes to the literature because, to our knowledge, it is the first randomized, controlled trial that evaluates the effectiveness of a multicomponent interventions, including reverse Trendelenburg position, designed to prevent nosocomial pneumonia in older adults admitted to the general ward.
